Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026)

Achieve Life Sciences' (ACHV) quarterly Prepaid Assets came in at $125000.0 in Q1 2026, down 92.88% YoY from $1.8 million in Q1 2025, and down 35.23% on a QoQ basis from $193000.0 in Q4 2025.

Analysis

Achieve Life Sciences (ACHV) Prepaid Assets (2010 - 2026) Analysis & Trends

Achieve Life Sciences (ACHV) has 17 years of Prepaid Assets data on file, last reported at $125000.0 in Q1 2026.

  • Quarterly Prepaid Assets fell 92.88% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 92.88% YoY) and the FY2025 annual result came in at $193000.0, down 90.84% from the prior year.
  • Prepaid Assets declined to $125000.0 in Q1 2026, from $193000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.6 million in Q3 2024 to a low of $125000.0 in Q1 2026.
  • A 5-year average of $1.6 million and a median of $1.5 million in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets surged 238.84% — and 2026, when it tumbled 92.88%.
  • Tracing ACHV's Prepaid Assets over 5 years: stood at $2.5 million in 2022, then plunged by 46.01% to $1.3 million in 2023, then jumped by 59.02% to $2.1 million in 2024, then plunged by 90.84% to $193000.0 in 2025, then slumped by 35.23% to $125000.0 in 2026.
  • The last three Prepaid Assets figures came in at $125000.0 (Q1 2026), $193000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 805,000.00
Mar 31, 2026 1.67 Mn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 1.94 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 1.76 Mn
Dec 31, 2024 2.11 Mn
Sep 30, 2024 2.62 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 1.31 Mn
Dec 31, 2023 1.33 Mn
Sep 30, 2023 1.90 Mn
Jun 30, 2023 958,000.00
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.45 Mn
Sep 30, 2022 2.62 Mn
Jun 30, 2022 1.46 Mn
Mar 31, 2022 1.36 Mn
Dec 31, 2021 1.42 Mn
Sep 30, 2021 1.27 Mn